Lipoprotein Metabolism and Bacterial Lipopolysaccharide in Parkinson's Disease Trial N/A Completed May 2, 2019
Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders Trial N/A Completed April 25, 2019
SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) Trial Phase 2 Completed April 18, 2019
The Effect of Resistance Training in Parkinson Disease: A Pilot Study Trial N/A Completed April 17, 2019
Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism Trial N/A Completed April 17, 2019
Contribution of Virtual Reality and Modelling in Falling Risk Assessment in Elderly and Parkinson's Disease Patients Trial N/A Unknown April 15, 2019
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease Trial Phase 2 Terminated April 15, 2019
Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations Trial Phase 2 Terminated April 11, 2019
Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease Trial N/A Completed April 11, 2019
Precision Medical Diagnosis for Parkinson's Disease - The Quantitative Analysis System for PET/MRI Images in Patients Trial N/A Unknown April 9, 2019
The Effect of Dual Tasking on Physical and Cognitive Functions in Patients With Parkinson Disease Trial N/A Completed April 4, 2019
neuroQWERTY: a Transparent Patient-centered Outcome Method to Quantify Parkinsonian Motor Signs for Drug Trials Trial N/A Completed April 3, 2019
The Effect of Parkinson Kinetigraph Recordings on the Management and Outcome in Parkinson's Disease Trial N/A Completed April 3, 2019
A Study of the Sense of Smell in Relatives of Parkinson's Disease Patients Trial N/A Completed April 2, 2019
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects Trial Phase 1 Terminated April 2, 2019